As of May 05, 2025, Theranexus SA (ALTHX.PA) has a market cap of $3.596 million USD. According to our data, Theranexus SA is ranked No.9087 in global market value.
Year | Market Cap | %Change |
---|---|---|
May 05, 2025 | $3.60 M |
-32.53%
|
Dec 31, 2024 | $5.33 M |
-48.39%
|
Dec 29, 2023 | $10.33 M |
-36.00%
|
Dec 30, 2022 | $16.14 M |
-64.65%
|
Dec 31, 2021 | $45.64 M |
2,554.16%
|
Dec 31, 2020 | $1.72 M |
-93.87%
|
Dec 31, 2019 | $28.03 M |
1,596.43%
|
Dec 31, 2018 | $1.65 M |
20.67%
|
Dec 29, 2017 | $1.37 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Santander
SAN
|
$111.03 B |
0.000 M
|
![]() Spain
|
![]() First Majestic Silver
AG
|
$3.03 B |
0.000 M
|
![]() Canada
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
Market Cap | = | ALTHX.PA Stock Price | * | ALTHX.PA Shares Outstanding |
= | $0.44 | * | 8.08 M | |
= | $3.60 M |